Hypertension

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

Eur Heart JPublished Secondary analysis of the SAVOR-TIMI 53 randomised trial

Authors' conclusion

In patients with diabetes and elevated CV risk, even after extensive adjustment for underlying disease burden, there was a persistent association for low DBP with subclinical myocardial injury and risk of MI.

Study context

Population
Patients with T2DM and elevated cardiovascular (CV) riskbiomarker subgroup
Participants
12,175 patients
Comparison
Baseline BP strata
Primary endpoint
Composite of:
  • CV death
  • MI
  • Ischaemic stroke
Methodological detailsbiomarker subgroup, stratified by baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP), adjusted for clinical covariates, NT-proBNP and high-sensitivity troponin-T (hsTnT)
  • Biomarker subgroup
  • Stratified by baseline SBP and DBP
  • Adjusted for clinical covariates, NT-proBNP and hsTnT

Primary result

As reported in the abstract

CV death, MI or ischaemic stroke by baseline SBP and DBP

U-shaped relationship of adjusted risk with baseline SBP and DBP

Pquadratic ≤ 0.01

Nadir SBP

130-140 mmHg

Nadir DBP

80-90 mmHg

Further findings

OutcomeAdjusted HR (95% CI)
MI2.30 (1.50–3.53)

hsTnT ≥14 ng/L

U-shaped relationship of adjusted odds with SBP and DBP
Pquadratic ≤ 0.01

Low DBP, elevated hsTnT and myocardial infarction (MI) excluding prior HF or NT-proBNP >median

Relationships remained

Original publication

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk. Eur Heart J. Published 31 January 2018. doi:10.1093/eurheartj/ehx809

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.